web analytics

Updated: Botox off the Block: Friday FDA FuckUps & Other Fun Around the Industry

Updated: Botox off the Block: Friday FDA FuckUps & Other Fun Around the Industry

UPDATED November 17, 2014: Actavis agrees to buy Botox-maker Allergan for $66 billion (middle of page).

November 14, 2014

Drug Companies Don’t Want You To See These Allegations Bloomberg

Corporate Integrity Agreements Do Not Work Killing My Career

Federal Judge unseals Chicago case much to the dismay of a few of the companies named in the suit. Might be good to see if any of these companies already signed a Corporate Integrity Agreement (CIA) with the DOJ on other cases, huh?

Checklist-of-Characteristic-of-The-Sociopathic-Business-Model (1)

FDA Approves 2 New Breast Implants for Allergan Mass+Device

Why Valeants Purchase of Allergan would create a Monopoly

Realted to Update 11/17/2013 Actavis agrees to buy Botox-maker Allergan for $66 billion

Wow-No wonder everyone wants to court the newly re-augmented Allergan.  This site in April of this year predicted that the sale of Johnson & Johnson’s Mentor’s highly anticipated PurTox (which was to compete with Allergan’s Botox) probably meant that Allergan was going on the “block” and suspected Valeant was nothing more than a pawn to drive up the asking price.  And also showed how the deal would actually create a breast augmentation monopoly.  The link below is a refresher with infographics.

UPDATED: Beauty is an Ugly Business: Infographic Valeant, Allergan & Mentor 

Any birdies chirping? IS Johnson & Johnson’s Mentor on the “block?” IF it is, it means that Johnson & Johnson would be in prime position to acquire Allergan.

UPDATED 11/17/2014  Actavis agrees to buy Botox-maker Allergan for $66 billion

This closes out the almost year-long Allergan case study-JNJ didn’t take Allergan but the page was correct that Valeant was there just to drive up the asking price. This one’s a draw.

Judge dismisses 76 Ethicon pelvic mesh lawsuits in Texas Mass+Device

Feds-Asleep-At-The-Wheel

A federal judge in Texas this week tossed 76 product liability lawsuits brought against JNJ Ethicon subsidiary over its Gynecare Prolift pelvic floor repair system, ruling that his court has no jurisdiction over the out-of-state plaintiffs.

Well, who fucked this one up? The attorneys or the federal court who allowed these cases to be filed in the first place? You know who didn’t fuck it up? THE JNJ MESH VICTIMS.  Quit re-victimizing these women!

Stay strong ladies #JNJ #Mesh #Victims this still isn’t a win for JNJ.

In other Mesh News:

*Breaking News! Jury Decides $26.7 Million for Four Women Injured by Boston Scientific Pelvic Mesh! | Mesh Medical Device Newsdesk

The nine-person jury entered into deliberations 2 pm today (Thursday, November 13) and delivered their verdict about four hours later. Thanks to Lana Keeton, medical device expert, who was in the courtroom to call it in to Mesh News Desk!

 

3 Comments
  • Diane schuricht
    Reply

    Wonder how much the judge got paid? Judges are corrupt and greedy. No justice for victims. No help

    November 14, 2014 at 5:28 pm
  • Whenever a case is filed in a court like that it stays (if that is the right word) the statute of limitations until a ruling is made, such as the one to “toss out” the cases. All of the plaintiffs are able to re-file their cases as long as they were dismissed “Without Prejudice”.

    If the cases were dismissed ” With Prejudice” the case is over.

    But every case everywhere depends on the specific facts of that particular case.

    November 20, 2014 at 7:06 pm

Post a Comment